These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 11825367)
1. [90Y glass microspheres intraradiopraxis of advanced hepatic carcinoma]. Huang C; Huang J; Yang W; Chen Y; Shen J; Chen W; Yang F; Chen H Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):206-8. PubMed ID: 11825367 [TBL] [Abstract][Full Text] [Related]
2. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer. Cao X; He N; Sun J; Tan J; Zhang C; Yang J; Lu T; Li J Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513 [TBL] [Abstract][Full Text] [Related]
3. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. Dancey JE; Shepherd FA; Paul K; Sniderman KW; Houle S; Gabrys J; Hendler AL; Goin JE J Nucl Med; 2000 Oct; 41(10):1673-81. PubMed ID: 11037997 [TBL] [Abstract][Full Text] [Related]
4. Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. Kennedy AS; Nutting C; Coldwell D; Gaiser J; Drachenberg C Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1552-63. PubMed ID: 15590187 [TBL] [Abstract][Full Text] [Related]
5. Hepatic vein tumor thrombus as a risk factor for excessive pulmonary deposition of microspheres during TheraSphere therapy for unresectable hepatocellular carcinoma. Fleming CJ; Andrews JC; Wiseman GA; Gansen DN; Roberts LR J Vasc Interv Radiol; 2009 Nov; 20(11):1460-3. PubMed ID: 19875064 [TBL] [Abstract][Full Text] [Related]
6. Liver transplantation for hepatocellular carcinoma after yttrium therapy: a case report. Sotiropoulos GC; Hilgard P; Antoch G; Nowak KM; Ertl J; Fouzas I; Molmenti EP; Sgourakis G; Beckebaum S; Paul A; Broelsch CE; Lang H Transplant Proc; 2008 Dec; 40(10):3804-5. PubMed ID: 19100496 [TBL] [Abstract][Full Text] [Related]
7. Yttrium-90 microspheres (TheraSphere and SIR-Spheres) for the treatment of unresectable hepatocellular carcinoma. Allison C Issues Emerg Health Technol; 2007 Sep; (102):1-6. PubMed ID: 17824141 [TBL] [Abstract][Full Text] [Related]
8. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Kennedy AS; Coldwell D; Nutting C; Murthy R; Wertman DE; Loehr SP; Overton C; Meranze S; Niedzwiecki J; Sailer S Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):412-25. PubMed ID: 16690429 [TBL] [Abstract][Full Text] [Related]
9. [Radioembolization with 32P-labelled glass microspheres for advanced hepatocellular carcinoma]. Yan L; Li L; Chen S Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):526-9. PubMed ID: 9594154 [TBL] [Abstract][Full Text] [Related]
10. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905 [TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy. Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558 [TBL] [Abstract][Full Text] [Related]
12. [Hepatic arterial infusion of 32P-radionuclide microspheres for radiation therapy of hepatocellular carcinoma]. Liang L; Huang J; Yin X; Lu M; Rao G; Ren Z; Li D; Kuang M Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):743-6. PubMed ID: 11829942 [TBL] [Abstract][Full Text] [Related]
13. Necrosis and apoptosis in hepatocellular carcinoma following low-dose versus high-dose preoperative chemoembolization. Lu W; Li YH; He XF; Zhao JB; Chen Y; Mei QL Cardiovasc Intervent Radiol; 2008; 31(6):1133-40. PubMed ID: 18584240 [TBL] [Abstract][Full Text] [Related]
14. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis. Goin JE; Salem R; Carr BI; Dancey JE; Soulen MC; Geschwind JF; Goin K; Van Buskirk M; Thurston K J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):195-203. PubMed ID: 15713920 [TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres. Houle S; Yip TK; Shepherd FA; Rotstein LE; Sniderman KW; Theis E; Cawthorn RH; Richmond-Cox K Radiology; 1989 Sep; 172(3):857-60. PubMed ID: 2549567 [TBL] [Abstract][Full Text] [Related]
16. Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma. Kamel IR; Reyes DK; Liapi E; Bluemke DA; Geschwind JF J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):49-56. PubMed ID: 17296704 [TBL] [Abstract][Full Text] [Related]
17. Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Carr BI Liver Transpl; 2004 Feb; 10(2 Suppl 1):S107-10. PubMed ID: 14762849 [TBL] [Abstract][Full Text] [Related]